Elevance Health Inc. (ELV) Tops Q2 EPS by 30c

Elevance Health Inc. (NYSE: ELV) reported Q2 EPS of $8.04, $0.30 better than the analyst estimate of $7.74. Revenue for the quarter came in at $38.5 billion versus the consensus estimate of $37.92 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• SpaceX: New Street Research sees 22% upside from proposed IPO price
• UBS Starts Motilal Oswal Financial Services Ltd (MOFS:IN) at Buy
• Anterix Inc. (ATEX) Tops Q4 EPS by 152c